The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
Tag: Alzheimer’s Disease
-
Alzheimer’s APOE4 Genetic Risk Targeted in Promising Trial
Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.
-
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
-
How to Know if You Have a Genetic Risk for Alzheimer’s
Chris Hemsworth recently revealed that he’s predisposed to dementia. Here’s how to find out if you’re at risk — and what to do if you are.